Oxfam statement on Novartis case in India

Oxfam is closely watching the outcome of Novartis’ endless and highly
damaging challenge to Section 3(d) of India’s Patent Act.  We are profoundly disappointed that Novartis has continued to pursue legal action against the Indian Government. Five years ago, hundreds of thousands of people called upon Novartis to drop its legal challenge against the Indian.  Today, over 2 billion people still lack regular access to affordable medicines, and yet Novartis has persisted.  Oxfam is seriously concerned that if Novartis succeeds, it will lead to long term and profound changes in India’s patent system that will undermine generic competition and access to affordable,low-cost medicines.

About these ads
This entry was posted in Indian Patent Law, Sec 3 (d), TRIPS plus and tagged , , , . Bookmark the permalink.

One Response to Oxfam statement on Novartis case in India

  1. Pingback: A victory for Novartis could spell death for millions | All India Drug Action Network (AIDAN)

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s